Picture [iito] Life Science Business Portals Media Data 2022 650x100px

Product › Details

antibody-drug conjugate (ADC)_o

	Next higher product group	antibody-drug conjugate (ADC)
	Status	2013-10-11 sales existent
	Organisation	Genentech (Group)
	Group	Roche (Group)
	Organisation 2	ImmunoGen Inc. (Nasdaq: IMGN)

Record changed: 2021-02-10

Picture [iito] Fighting Customers 650x100px

More documents for antibody-drug conjugate (ADC)

[1] ADC Therapeutics S.A.. (6/13/22). "Press Release: ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer". Lausanne....
[2] ADC Therapeutics S.A.. (5/9/22). "Press Release: ADC Therapeutics Announces CEO Transition. Co-Founder Chris Martin Transitions CEO Role to Industry Veteran Ameet Mallik". Lausanne....
[3] Byondis B.V.. (5/3/22). "Press Release: Byondis and Medac Enter into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)". Nijmegen & Wedel....
[4] Veraxa Biotech GmbH. (3/22/22). "Press Release: Torsten Buergermeister Joins Veraxa Biotech GmbH as Chief Financial Officer". Heidelberg....
[5] Heidelberg Pharma AG. (3/10/22). "Press Release: Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117". Ladenburg....
[6] Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg....
[7] ADC Therapeutics S.A.. (1/18/22). "Press Release: ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize Zynlonta(loncastuximab tesirine-lpyl) in Japan". Lausanne....
[8] Emergence Therapeutics AG. (12/7/21). "Press Release: Emergence Therapeutics Raises €87 Million Series A Financing to Advance Nectin-4 ADC". Duisburg....
[9] Mablink Bioscience S.A.S.. (10/21/21). "Press Release: Mablink Bioscience and Emergence Therapeutics Enter into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy". Lyon & Duisburg....
[10] Atbtherapeutics. (10/5/21). "Press Release: Atbtherapeutics Expands Leadership Team and Scientific Advisory Board with Pharmaceutical Industry Experts". Aye....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)